Clinical Trials · NCT01224405

Prostate Cancer, Androgen Deprivation Withdrawal and Intermittent Chemotherapy

UnknownPhase 3Gonadorelin (Unclear)
Phase
Phase 3
Recruitment status
Unknown
Sponsor
University of Turin, Italy
Enrollment
600
Start date
Apr 2010
Locations
32 sites, Italy
Primary endpoint
overall survival
View Gonadorelin compound reference